• Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

    Thumbnail Image

    Files

    1-s2.0-S0959804917310018-main.pdf (673.6 KB)

    Date

    2017

    Authors

    Journal Title

    Journal ISSN

    Volume Title

    Publisher

    Access

    openAccess

    Embargo end date

    Citation

    Ferry, D. and Billingham, L. and Jarrett, H. and Dunlop, D. and Woll, P.J. and Nicolson, M. and Shah, R. and Thompson, J. and Spicer, J. and Muthukumar, D. and Skailes, G. and Leonard, P. and Chetiyawardana, A.D. and Wells, P. and Lewanski, C. and Crosse, B. and Hill, M. and Gaunt, P. and O'Byrne, K., Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial, European Journal of Cancer, 83, 2017, 302-312

    Abstract

    Description

    PUBLISHED
    cited By 1

    URI

    http://hdl.handle.net/2262/82623

    Collections

    Clinical Medicine (Scholarly Publications)
    RSS Feeds

    Endorsement

    Review

    Supplemented By

    Referenced By

    Keywords

    Author's Homepage: http://people.tcd.ie/obyrneke

    Author: O'BYRNE, KEN

    Type of material: Journal Article